Asia · Regional markets · Business Standard

Mankind Pharma soars 11% in 2 days on strong Q2 earnings; brokerages upbeat

Published by Business Standard · India 1 h ago

Mankind Pharma share price: Going ahead, improving domestic volumes, rising chronic contribution and sustained export momentum are expected to support growth, say analysts.

Read the full article on Business Standard Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.business-standard.com)

Also worth reading

Tech in Asia

Paytm’s Q2 profit jumps to $24m as revenue grows

The Straits Times Business

Bond market is a buy right now, J.P. Morgan Asset Management’s fixed income head says

The Business Times

Mankind Pharma soars 11% in 2 days on strong Q2 earnings; brokerages upbeat

Share

Also worth reading

Paytm’s Q2 profit jumps to $24m as revenue grows

Bond market is a buy right now, J.P. Morgan Asset Management’s fixed income head says

Singapore-led Asean network aims to spot emerging labour market trends

IBK Bank’s nine-month profit tops 2 tn won for first time

IMF consulted before fixing wheat price, says Rana Tanveer

FE Exclusive | ‘We are expanding routes, preparing for international flights’: Noida Airport CEO